Kymera Therapeutics, Inc. - Common Stock (KYMR)

CUSIP: 501575104

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+6,195,480
Put/Call ratio
105%
SEC-reported price per share
$83.29
Number of holders
255
Value change
+$522,635,907
Number of buys
129
Open additional details 1 more signal available
Number of sells
111
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
82,580,091

Security key

501575104

Report period

Q1 2026

Institutions

255

Top holders

10

Ownership snapshot

Top reported holders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
4/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 14% 11 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 14%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 4
FMR LLC 14%
BAKER BROS. ADVISORS LP 11%
T. Rowe Price Investment Manageme... 6.7%
WELLINGTON MANAGEMENT GROUP LLP 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
14%
Reported 13D/G · 31 Mar 2026
$1,034,158,808
11,681,450 shares
+$243,712,112 31 Mar 2026
BAKER BROS. ADVISORS LP
13F 13D/G
Company
11%
Reported 13D/G · 09 Dec 2025
$673,620,000
8,657,242 shares
— 31 Dec 2025
T. Rowe Price Investment Management, Inc.
13D/G 13F
Company
6.7%
Reported 13D/G · 31 Mar 2026
$483,396,552
5,460,257 shares
$0 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP
13D/G 13F
Company
4.8%
Reported 13D/G · 31 Mar 2026
$344,353,990
3,889,687 shares
-$46,322,968 31 Mar 2026
Atlas Venture Fund X, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$235,830,130
5,504,905 shares
— 11 Mar 2024
ATLAS VENTURE ASSOCIATES X, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$173,161,222
5,763,012 shares
— 11 Aug 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
255
Shares
96,291,386
Rows available
255
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
255
Q1 2026 holders
255
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .